DRUG CHARACTERISTICS ASSOCIATED WITH GENERIC UPTAKE AFTER LOSS OF MARKET EXCLUSIVITY

被引：0

作者：

Rome, Benjamin N. ^{[1
,2
]}

Lee, ChangWon C. ^{[1
]}

Kesselheim, Aaron S. ^{[1
,2
]}

机构：

[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, 75 Francis St, Boston, MA 02115 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

来源：

JOURNAL OF GENERAL INTERNAL MEDICINE | 2020年 / 35卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：S97 / S97

页数：1

共 50 条

[1] Generic Competition and Market Exclusivity Periods in Pharmaceuticals
Grabowski, Henry G.
Kyle, Margaret
MANAGERIAL AND DECISION ECONOMICS, 2007, 28 (4-5) : 491 - 502
[2] US courts disagree on generic drug exclusivity
Chahine, K
NATURE BIOTECHNOLOGY, 1998, 16 (02) : 132 - 132
[3] US courts disagree on generic drug exclusivity
Ken Chahine
Nature Biotechnology, 1998, 16 : 132 - 132
[4] THE IMPACT OF OUT-OF-POCKET SPENDING ON THE PENETRATION OF GENERIC DRUGS AFTER THE EXPIRY OF THE MARKET EXCLUSIVITY
Cioni, L.
Tettamanti, A.
Urbinati, D.
VALUE IN HEALTH, 2019, 22 : S607 - S607
[5] Market Exclusivity and Changes in Competition and Prices Associated With the US Food and Drug Administration Unapproved Drug Initiative
Gunter, Simon J.
Kesselheim, Aaron S.
Rome, Benjamin N.
JAMA INTERNAL MEDICINE, 2021, 181 (08) : 1124 - 1126
[6] Drug Discovery Market Exclusivity After KSR:The Challenge to Pharmaceutical Scientists and the US Congress
Wolff, Manfred E.
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (08) : 3044 - 3054
[7] The Redemption of Drug Patent Linkage System: The Dilemma and Improvement in the Qualification System of Market Exclusivity Period for China's First Generic Drug
Zhang, Huaiyin
Ji, Yuqi
BIOTECHNOLOGY LAW REPORT, 2024, 43 (06) : 318 - 331
[8] A Study of "Drug Entry Lags" Between Japan and the US: Compering the Timing of a New Drug Entry, Generic Entry and Market Exclusivity Periods
Masuda, Sachiko
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 321 - 321
[9] Modifying the Criteria for Granting Orphan Drug Market Exclusivity
Socal, Mariana P.
Parasrampuria, Sonal
Anderson, Gerard F.
VALUE IN HEALTH, 2020, 23 (11) : 1470 - 1476
[10] The influence of market exclusivity on drug availability and medical innovations
Gregory J. Glover
The AAPS Journal, 9

← 1 2 3 4 5 →